Nous utilisons des cookies pour optimiser le site internet. En poursuivant votre navigation sur ce site ou en fermant cette fenêtre, vous acceptez notre politique concernant l'utilisation de cookies.

Veuillez noter que cette partie du site n’est disponible qu’en Anglais
Imprimir Partager

Christoffer Lorenzen appointed member of the Executive Board of Chr. Hansen Holding A/S

Christoffer Lorenzen appointed member of the Executive Board of Chr. Hansen Holding A/S
Press ReleaseJan 29. 2018 09:07 GMT

Christoffer Lorenzen (42) is Executive Vice President (EVP) of Chr. Hansen’s largest business unit, Food Cultures & Enzymes. He joined Chr. Hansen in March 2008 and has held various positions in Sales and Marketing, including Director of Marketing in our Animal Health & Nutrition Business, and Vice President of Central & Eastern Europe. In 2013 he was appointed Senior Vice President of Commercial Development in the Cultures & Enzymes Division and in 2016 he was appointed EVP of the Food Cultures and Enzymes Business Unit.

Prior to joining Chr. Hansen, Mr Lorenzen was employed at H. Lundbeck A/S, a global specialty pharmaceutical company, where he served as Head of Corporate Strategy and M&A as well as Corporate Secretary.

Christoffer Lorenzen holds a Master in Business (Marketing) 2002 from the Copenhagen Business School.

“The appointment of Christoffer Lorenzen to the Executive Board of Chr. Hansen had been planned already before the announcement of Cees de Jong stepping back, as FC&E has normally always been represented at the Executive Board.” says Ole Andersen Chairman of Chr. Hansen.

CEO Cees de Jong adds: “Christoffer has been with Chr. Hansen for the past 10 years and has a deep knowledge and understanding of the company, its history and its potential. By joining, Christoffer adds core knowledge and expertise to the Executive Board.”

The company strategy, priorities and financial guidance remain the same.

As of 1 February, 2018, the Executive Board consists of: CEO Cees de Jong, CFO Søren Westh Lonning, CSO Thomas Schäfer, and EVP Christoffer Lorenzen. The Executive Board is appointed by the Board of Directors and is, together with their colleagues in the Corporate Leadership Team, responsible for day-to-day management and compliance with the guidelines and directions given by the Board of Directors.

For further information, please contact:
Martin Riise, Head of Investor Relations, Tel: +45 53 39 22 50
Helle Rexen, Interim Head of Media Relations, Tel: +45 20 74 28 40


Chr. Hansen est une entreprise de bioscience internationale qui met au point des solutions naturelles pour les industries des secteurs alimentaire, nutritionnel, pharmaceutique et agricole. Les produits comprennent des cultures, des enzymes, des probiotiques et des colorants naturels ; toutes les solutions s'appuient sur de fortes compétences en matière de recherche et développement, doublées d'investissements significatifs en matière de technologie. Le chiffre d'affaires pour l'exercice 2015/16 est de 949 millions d'euros. La société emploie plus de 2 800 salariés motivés dans 30 pays et les unités de fabrication principales sont implantées au Danemark, en France, aux Etats-Unis et en Allemagne. Chr. Hansen a été fondée en 1874 et est cotée au Nasdaq de Copenhague.

Que recherchez-vous ?

Partager cette page

Selectionner votre langue